Susanna Gatti High, Chief Operating Officer at Dyne Therapeutics, Inc. (DYN), sold 4,987 shares at $28.20 ($141K) on 2024-05-16, disclosed to the SEC on 2024-05-17.
Scheduled sale ($141k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.20 | 2,249 | $63K | 45.0% |
| 2 | $28.20 | 2,249 | $63K | 45.0% |
| 3 | $28.59 | 489 | $14K | 9.9% |
| Total | $28.24 avg | 4,987 | $141K | 100% |
| Filing → |
| DYN | SELL | 2024-08-20 | $248K | — | Filing → |
| DYN | SELL | 2024-07-03 | $722K | — | Filing → |
| DYN | SELL | 2024-06-24 | $2.4M | — | Filing → |